Garlic for the common cold.

Cochrane Database Syst Rev

Faculty of Medicine, Dentistry & Health Sciences, The University ofWestern Australia, Crawley, WA, 6009, Australia.

Published: November 2014

AI Article Synopsis

  • Garlic is thought to possess antimicrobial and antiviral properties that could help prevent or treat the common cold, though rigorous research is limited.
  • A search of various medical databases identified eight relevant trials, but only one met the criteria for inclusion: it involved 146 participants comparing garlic supplements to a placebo over 12 weeks.
  • Results showed a significant reduction in the occurrence of colds in the garlic group (24 cases) compared to the placebo group (65 cases), but recovery times were similar between the two groups; overall, only one study limits the strength of the conclusions drawn.

Article Abstract

Background Garlic is alleged to have antimicrobial and antiviral properties that relieve the common cold, among other beneficial effects. There is widespread usage of garlic supplements. The common cold is associated with significant morbidity and economic consequences. On average, children have six to eight colds per year and adults have two to four.Objectives To determine whether garlic (Allium sativum) is effective for the prevention or treatment of the common cold, when compared to placebo, no treatment or other treatments.Search methods We searched CENTRAL (2014, Issue 7),OLDMEDLINE (1950 to 1965),MEDLINE (January 1966 to July week 5, 2014), EMBASE(1974 to August 2014) and AMED (1985 to August 2014).Selection criteria Randomised controlled trials of common cold prevention and treatment comparing garlic with placebo, no treatment or standard treatment.Data collection and analysis Two review authors independently reviewed and selected trials from searches, assessed and rated study quality and extracted relevant data.Main results In this updated review, we identified eight trials as potentially relevant from our searches. Again, only one trial met the inclusion criteria.This trial randomly assigned 146 participants to either a garlic supplement (with 180 mg of allicin content) or a placebo (once daily)for 12 weeks. The trial reported 24 occurrences of the common cold in the garlic intervention group compared with 65 in the placebo group (P value < 0.001), resulting in fewer days of illness in the garlic group compared with the placebo group (111 versus 366). The number of days to recovery from an occurrence of the common cold was similar in both groups (4.63 versus 5.63). Only one trial met the inclusion criteria, therefore limited conclusions can be drawn. The trial relied on self reported episodes of the common cold but was of reasonable quality in terms of randomisation and allocation concealment. Adverse effects included rash and odour. Authors' conclusions There is insufficient clinical trial evidence regarding the effects of garlic in preventing or treating the common cold. A single trial suggested that garlic may prevent occurrences of the common cold but more studies are needed to validate this finding. Claims of effectiveness appear to rely largely on poor-quality evidence.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465033PMC
http://dx.doi.org/10.1002/14651858.CD006206.pub4DOI Listing

Publication Analysis

Top Keywords

common cold
40
compared placebo
12
garlic
10
cold
10
common
9
prevention treatment
8
placebo treatment
8
trial met
8
met inclusion
8
occurrences common
8

Similar Publications

Background/objectives: GCL1815 is a lactic acid bacterium thought to activate dendritic cells. This randomized, placebo-controlled, double-blind study aimed to evaluate the effects of GCL1815 on human dendritic cells and the onset of the common cold.

Methods: Two hundred participants were divided into two groups and took capsules containing either six billion GCL1815 cells or placebo for 8 weeks.

View Article and Find Full Text PDF

Packaging materials mainly serve the function of protecting products. The most common representative of this group is poly(ethylene terephthalate) (PET), which is not biodegradable and therefore, its waste might be burdensome to the environment. Thus, this work aims to develop outlines for obtaining polyester-based systems, preferably biobased ones, intended for the packaging industry and their detailed characterization.

View Article and Find Full Text PDF

The Effects of Artificial vs. Natural Rearing on Growth Performance, Thyroid Hormone Levels, Locomotor Activity, Carcass Traits and Meat Quality Characteristics in Chios Lambs.

Animals (Basel)

December 2024

Laboratory of Animal Husbandry, Department of Animal Production, Faculty of Agriculture, Forestry and Natural Environment, School of Agriculture, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

Artificial rearing (AR) of lambs is nowadays a common practice in Mediterranean dairy sheep production systems to enhance the milk available for cheese or yoghurt manufacturing. The sufficient growth of lambs in an AR system is vital for the economic success of dairy sheep farms. However, AR is often associated with negative impacts on the performance and physiology of lambs.

View Article and Find Full Text PDF

Skin Hydration by Natural Moisturizing Factors, a Story of H-Bond Networking.

J Phys Chem B

January 2025

INSERM U1248 Pharmacology & Transplantation, Univ. Limoges, CBRS, 2 Rue du Prof. Descottes, F-87000 Limoges, France.

Dry skin is a common condition that is experienced by many. Besides being particularly present during the cold season, various diseases exist all year round, leading to localized xerosis. To prevent it, the skin is provided with natural moisturizing factors (NMFs).

View Article and Find Full Text PDF

The influenza virus is classified as a single-stranded negative-sense RNA virus in Orthomyxoviridae family, with epidemiological properties distinct from common cold. Previous studies have found that influenza infection can cause cardiac damage through various pathways, and patients with cardiovascular diseases are at relatively higher risk of adverse disease outcomes. Influenza vaccination has been proven to provide protective effect on patients with cardiovascular diseases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!